Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer was focused on recently. A caller asked if the stock lives up to the hype or if it is too speculative. Cramer replied: “Okay, I had Recursion on when they were 9, 10. They did an equity offering. The stock got clobbered. It’s been down. Now, it’s a meme stock, and I can predict, unfortunately, that when it’s a meme stock, it’s going to go up every day. They’ve adopted this stock. They want to take it higher. I don’t know why, bu ...